Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cycling cancer persister cells arise from lineages with distinct programs
Yaara Oren, Michael Tsabar, Michael S. Cuoco, et al.
Nature (2021) Vol. 596, Iss. 7873, pp. 576-582
Open Access | Times Cited: 350

Showing 1-25 of 350 citing articles:

The role of ROS in tumour development and progression
Eric C. Cheung, Karen H. Vousden
Nature reviews. Cancer (2022) Vol. 22, Iss. 5, pp. 280-297
Closed Access | Times Cited: 1018
Senescence and cancer — role and therapeutic opportunities
Clemens A. Schmitt, Boshi Wang, Marco Demaria
Nature Reviews Clinical Oncology (2022) Vol. 19, Iss. 10, pp. 619-636
Open Access | Times Cited: 453
Rational combinations of targeted cancer therapies: background, advances and challenges
Haojie Jin, Liqin Wang, René Bernards
Nature Reviews Drug Discovery (2022) Vol. 22, Iss. 3, pp. 213-234
Closed Access | Times Cited: 253
Applications of single-cell RNA sequencing in drug discovery and development
Bram Van de Sande, Joon Sang Lee, Euphemia Mutasa-Gottgens, et al.
Nature Reviews Drug Discovery (2023) Vol. 22, Iss. 6, pp. 496-520
Open Access | Times Cited: 207
Persister cancer cells: Iron addiction and vulnerability to ferroptosis
Raphaël Rodriguez, Stuart L. Schreiber, Marcus Conrad
Molecular Cell (2021) Vol. 82, Iss. 4, pp. 728-740
Open Access | Times Cited: 175
Cancer cell heterogeneity and plasticity: A paradigm shift in glioblastoma
Yahaya A Yabo, Simone P. Niclou, Anna Golebiewska
Neuro-Oncology (2021) Vol. 24, Iss. 5, pp. 669-682
Open Access | Times Cited: 172
A cellular hierarchy in melanoma uncouples growth and metastasis
Panagiotis Karras, Ignacio Bordeu, Joanna Poźniak, et al.
Nature (2022) Vol. 610, Iss. 7930, pp. 190-198
Open Access | Times Cited: 161
What is cancer metabolism?
Lydia W.S. Finley
Cell (2023) Vol. 186, Iss. 8, pp. 1670-1688
Open Access | Times Cited: 160
Cancer cell plasticity during tumor progression, metastasis and response to therapy
Andrea Pérez-González, Kevin Bévant, Cédric Blanpain
Nature Cancer (2023) Vol. 4, Iss. 8, pp. 1063-1082
Open Access | Times Cited: 148
Copper-Based Metal–Organic Framework Overcomes Cancer Chemoresistance through Systemically Disrupting Dynamically Balanced Cellular Redox Homeostasis
Jia Liu, Ye Yuan, Yanni Cheng, et al.
Journal of the American Chemical Society (2022) Vol. 144, Iss. 11, pp. 4799-4809
Closed Access | Times Cited: 142
Sublethal cytochrome c release generates drug-tolerant persister cells
Halime Kalkavan, Jinan Chen, Jeremy Chase Crawford, et al.
Cell (2022) Vol. 185, Iss. 18, pp. 3356-3374.e22
Open Access | Times Cited: 134
Diverse clonal fates emerge upon drug treatment of homogeneous cancer cells
Yogesh Goyal, Gianna T. Busch, Maalavika Pillai, et al.
Nature (2023) Vol. 620, Iss. 7974, pp. 651-659
Open Access | Times Cited: 102
ALK-positive lung cancer: a moving target
Jaime L. Schneider, W. Marston Linehan, Alice T. Shaw
Nature Cancer (2023) Vol. 4, Iss. 3, pp. 330-343
Closed Access | Times Cited: 96
Towards precision oncology with patient-derived xenografts
Eugenia R. Zanella, Elena Grassi, Livio Trusolino
Nature Reviews Clinical Oncology (2022) Vol. 19, Iss. 11, pp. 719-732
Closed Access | Times Cited: 88
H3K27me3 conditions chemotolerance in triple-negative breast cancer
Justine Marsolier, Pacôme Prompsy, Adeline Durand, et al.
Nature Genetics (2022) Vol. 54, Iss. 4, pp. 459-468
Open Access | Times Cited: 82
AXL and Error-Prone DNA Replication Confer Drug Resistance and Offer Strategies to Treat EGFR-Mutant Lung Cancer
Ashish Noronha, Nishanth Belugali Nataraj, Joo Sang Lee, et al.
Cancer Discovery (2022) Vol. 12, Iss. 11, pp. 2666-2683
Open Access | Times Cited: 77
Drug-Tolerant Persister Cells in Cancer Therapy Resistance
Pavan Kumar Dhanyamraju, Todd D. Schell, Shantu Amin, et al.
Cancer Research (2022) Vol. 82, Iss. 14, pp. 2503-2514
Open Access | Times Cited: 76
Drug-tolerant persister cells in cancer: the cutting edges and future directions
Yi Pu, Lu Li, Haoning Peng, et al.
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 11, pp. 799-813
Closed Access | Times Cited: 69
Cancer metastasis: Molecular mechanisms and clinical perspectives
Sameer Ullah Khan, Kaneez Fatima, Fayaz Malik, et al.
Pharmacology & Therapeutics (2023) Vol. 250, pp. 108522-108522
Closed Access | Times Cited: 62
TGF-β, EMT, and resistance to anti-cancer treatment
Xuecong Wang, Pieter J.A. Eichhorn, Jean Paul Thiery
Seminars in Cancer Biology (2023) Vol. 97, pp. 1-11
Open Access | Times Cited: 59
Mammalian SWI/SNF chromatin remodeling complexes promote tyrosine kinase inhibitor resistance in EGFR-mutant lung cancer
Fernando J. de Miguel, Claudia Gentile, William W. Feng, et al.
Cancer Cell (2023) Vol. 41, Iss. 8, pp. 1516-1534.e9
Open Access | Times Cited: 53
Mechanisms of Acquired Resistance and Tolerance to EGFR Targeted Therapy in Non-Small Cell Lung Cancer
Houssein Chhouri, David Alexandre, Luca Grumolato
Cancers (2023) Vol. 15, Iss. 2, pp. 504-504
Open Access | Times Cited: 47
Longitudinal single-cell profiling of chemotherapy response in acute myeloid leukemia
Matteo Maria Naldini, Gabriele Casirati, Matteo Barcella, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 46
Sensitization of cancer cells to ferroptosis coincident with cell cycle arrest
Jason Rodencal, Nathan G. Kim, Andrew He, et al.
Cell chemical biology (2023) Vol. 31, Iss. 2, pp. 234-248.e13
Closed Access | Times Cited: 46
Dormancy, stemness, and therapy resistance: interconnected players in cancer evolution
Federica Francescangeli, Maria Laura De Angelis, Rachele Rossi, et al.
Cancer and Metastasis Reviews (2023)
Open Access | Times Cited: 44
Page 1 - Next Page

Scroll to top